Sudarat Kiat-Amnuay
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (3)
Objective Osteoradionecrosis of the jaw (ORNJ) is a chronic radiation-associated toxicity that lacks standardized classification criteria and treatment guidelines. Understanding early signs of tissue injury could help us better predict, prevent, and conservatively manage ORN. Our primary aims were to identify initial clinically-detected signs of ORN, determine the frequency of imaging-detected ORNJ, and validate the ability to classify cases using the novel system, ClinRad. Study Design A retrospective electronic health record review of 91 patients treated for head and neck cancer at The University of Texas MD Anderson Cancer Center with suspected ORN was performed by an Oral Medicine specialist to identify initial signs of ORN. Patients who received reirradiation to the head and neck or did not have enough evidence of ORN were excluded. A descriptive analysis was performed. Results 51 patients met the inclusion criteria. Half (53%) presented with imaging findings and exposed bone. Imaging findings in the absence of bone exposure were identified in 37%, of which disease progression was observed in 26%. All cases were classifiable using ClinRad. Conclusion Subclinical signs of bony changes consistent with ORN may be evident on imaging without exposed bone, supporting the use of imaging surveillance. ClinRad provided a mechanism to classify all cases at early onset. Data availability statement Anonymized data for the reported analyses is made publicly available on figshare at 10.6084/m9.figshare.28292186. Reporting guideline compliance statement In accordance with the EQUATOR Network (Enhancing the QUAlity and Transparency Of health Research) guidance, we have utilized the RECORD checklist, a guideline for the “REporting of studies Conducted using Observational Routinely-collected health data” (Benchimool El at al., 2015) The RECORD checklist is provided as a Supplementary file and available via 10.6084/m9.figshare.28292219. Data was anonymized in accordance with the EQUATOR guideline “Preparing raw clinical data for publication: guidance for journal editors, authors, and peer reviewers” (Hrynaszkiewicz I et al., 2010).
Year:
2025
Purpose Osteoradionecrosis of the jaw (ORNJ) is a severe iatrogenic disease characterized by bone death after radiation therapy (RT) to the head and neck. With over 9 published definitions and at least 16 diagnostic/staging systems, the true incidence and severity of ORNJ are obscured by lack of a standard for disease definition and severity assessment, leading to inaccurate estimation of incidence, reporting ambiguity, and likely under-diagnosis worldwide. This study aimed to achieve consensus on an explicit definition and phenotype of ORNJ and related precursor states through data standardization to facilitate effective diagnosis, monitoring, and multidisciplinary management of ORNJ. Methods The ORAL Consortium comprised 69 international experts, including representatives from medical, surgical, radiation oncology, and oral/dental disciplines. Using a web-based modified Delphi technique, panelists classified descriptive cases using existing staging systems, reviewed systems for feature extraction and specification, and iteratively classified cases based on clinical/imaging feature combinations. Results The Consortium ORNJ definition was developed in alignment with SNOMED-CT terminology and recent ISOO-MASCC-ASCO guideline recommendations. Case review using existing ORNJ staging systems showed high rates of inability to classify (up to 76%). Ten consensus statements and nine minimum data elements (MDEs) were outlined for prospective collection and classification of precursor/ORNJ stages. Conclusion This study provides an international, consensus-based definition and MDE foundation for standardized ORNJ reporting in cancer survivors treated with RT. Head and neck surgeons, radiation, surgical, medical oncologists, and dental specialists should adopt MDEs to enable scalable health information exchange and analytics. Work is underway to develop both a human- and machine-readable knowledge representation for ORNJ (i.e., ontology) and multidisciplinary resources for dissemination to improve ORNJ reporting in academic and community practice settings.
Year:
2024
There are often bonding problems between acrylic resins and silicone. PEEK (polyetheretherketone), which is a high-performance polymer, has great potential for the implant, and fixed or removable prosthodontics. The aim of this study was to evaluate the effect of different surface treatments on PEEK to be bonded to maxillofacial silicone elastomers. A total of 48 specimens were fabricated from either PEEK or PMMA (Polymethylmethacrylate) (n = 8). PMMA specimens acted as a positive control group. PEEK specimens were divided into five study groups as surface treatments as control PEEK, silica-coating, plasma etching, grinding, or nano-second fiber laser. Surface topographies were evaluated by scanning electron microscopy (SEM). A platinum-primer was used on top of all specimens including control groups prior to silicone polymerization. The peel bond strength of the specimens to a platinum-type silicone elastomer was tested at a cross-head speed of 5 mm/min. The data were statistically analyzed (α = 0.05). The control PEEK group showed the highest bond strength (p < 0.05) among the groups. No statistical difference was found between control PEEK, grinding, or plasma etching groups (p > 0.05). The lowest bond strength was seen in the laser group, which was not statistically different from silica-coating (p > 0.05), and statistically different from control PEEK, grinding, or plasma groups (p < 0.05). Positive control PMMA specimens had statistically lower bond strength than either control PEEK or plasma etching groups (p < 0.05). All specimens exhibited adhesive failure after a peel test. The study results indicate that PEEK could serve as a potential alternative substructure for implant-retained silicone prostheses.
Year:
2023
Collaborators (28)
richard shaw
Clinical Professor
University of Liverpool
Lisanne van Dijk
Associate professor & Technical physician
University Medical Center Groningen
Antti A. Mäkitie
Professor and Chair
University of Helsinki
Jørgen Johansen
University of Southern Denmark
Katherine Hutcheson
Associate Professor
The University of Texas MD Anderson Cancer Center
Muhammad Walji
Chair and Professor
The University of Texas Health Science Center at Houston
Vinita Takiar
-
Stephen Lai
Professor
The University of Texas MD Anderson Cancer Center
Amy Moreno
Assistant Professor
The University of Texas MD Anderson Cancer Center
Alessandro Villa
Professor
Florida International University
Paolo Bossi
IRCCS Humanitas Research Hospital
Alexander Lin
Morton M. Kligerman, MD Endowed Professor
University of Pennsylvania
Simon Young
Professor and Department Chair
The University of Texas Health Science Center at Houston
Teresa Guerrero Urbano
Adjunct Reader
King's College London
James Bates
Associate Professor
Emory University
Marco Magalhaes
Associate Professor
University of Toronto
Max Witjes
University Medical Center Groningen
Jillian Rigert
The University of Texas MD Anderson Cancer Center
Mabi Singh
Professor
Tufts University School of Dental Medicine
Daphna Gelblum
Memorial Sloan Kettering Cancer Center
Ugur Selek
Professor
Koç University
Theresa Hofstede
Professor
The University of Texas MD Anderson Cancer Center
Yvonne Mowery
Associate Professor
UPMC Hillman Cancer Center
Abdallah Mohamed
Assistant Professor
Baylor College of Medicine
Zaphanlene Kaffey
The University of Texas MD Anderson Cancer Center
Alex Won
Associate Professor
The University of Texas MD Anderson Cancer Center
Zayne Belal
Assistant Professor
University of Texas Medical Branch
Clifton D Fuller
Professor (Tenured)
The University of Texas MD Anderson Cancer Center
Make your next move.
Prepare your application
Review drafts before you send them.